Donor stories
We are very grateful that so many of you recognise the cutting-edge research carried out at The Institute of Cancer Research, either by leaving a legacy in your Will or by funding our researchers to work on a particular aspect of cancer research.
Dave World takes on special challenge in Mum's memory
Dave World is set to complete three of the capital city’s toughest sports events and be awarded London Classics medal
One More City
Christine O’Connell set up the annual fundraising campaign One More City after she was diagnosed with breast cancer. She and her teammates are cycling to raise £120,000 to fund a four year PhD at The Institute of Cancer Research.
Rosetrees Trust
Rosetrees Trust provides grants to fund research projects that will impact significantly on human health disease, including cancer. Their commitment to our mission to defeat cancer, has led to them to fund nearly £3m of our research programmes since 2001.
The CRIS Cancer Foundation
CRIS was founded by Lola Manterola and her husband Diego Megia after Lola’s diagnosis with multiple myeloma. They are investing in research in the UK and France, as well as in their native Spain, to give hope to all those cancer patients who are not responding to current standard treatments. They share our goal to make the discoveries that defeat cancer.
Masonic Charitable Foundation
The Masonic Charitable Foundation has made a generous pledge of £143,440 over four years towards our PhD studentship programme, enabling the ICR to offer an additional studentship to a talented young scientist. This represents a significant investment in the future of cancer research and the advancement of knowledge at the ICR, and in the cancer research community globally.
Dr Sally Gold
Husband’s memory inspires donation towards novel lung cancer research.
Leon Gold’s love for life has inspired his wife Sally to leave an in-memory gift to us, after he tragically passed away from lung cancer in April 2012.
The Bob Champion Cancer Trust
The Bob Champion Cancer Trust are funding research projects that will help us understand cancer risk and predict the evolution of a patient's prostate cancer.
The Oracle Cancer Trust
The Oracle Cancer Trust supports the development of pioneering scientific and clinical investigations in the field of head and neck cancer. Over the past few years the Trust has generously supported a number of our cutting-edge research projects, with awards totalling more than £1 million.